[Correction by verapamil of the disturbed neuroregulatory systems during early atherogenesis].
Kobozeva
L P
LP
Klimenko
E D
ED
Michunskaia
A B
AB
Pozdniakov
O M
OM
D000320:Adrenergic Fibers / Q000473:pathology*; D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D001808:Blood Vessels / Q000294:innervation*; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000503:physiopathology; D008074:Lipoproteins / Q000097:blood; D008297:Male; D008833:Microcirculation; D011817:Rabbits; D017539:Tunica Intima / Q000473:pathology; D014700:Verapamil / Q000494:pharmacology*
D002121:Calcium Channel Blockers; D008074:Lipoproteins; D014700:Verapamil